Article

Gout Discovery at Duke University Could Lead to New Treatment

A new treatment for treating Gout can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments.

Thanks to a study from Duke University, a new way of treating gout is being explored that can normalize levels of uric acid in the blood within hours in patients who have failed to respond to any other treatments. The experimental new drug being tested targets and attacks excess uric acid, the root cause of Gout, and converts it into another chemical that is released through the urine. Researchers have even found that the drug reduces the size of crystalline deposits of uric acid, a common occurrence in Gout patients.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.